Copper inhibits activated protein C: Protective effect of human albumin and an analogue of its high-affinity copper-binding site, d-DAHK

Biochemical and Biophysical Research Communications

Volumn 290, Issue 5, 2002, Pages 1388-1392

  Bar Or, David ^a,b   Rael, Leonard T ^a,b   Winkler, James V ^a,b   Yukl, Richard L ^a,b   Thomas, Gregory W ^a,b   Shimonkevitz, Richard P ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b DMI BioSciences Inc   (United States)

Author keywords

Acidosis; Activated protein C; Anticoagulation; Asp Ala His Lys; Copper; DAHK; Human albumin; Inflammation; Ischemia; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; COPPER; COPPER CHLORIDE; DEXTRO ASPARTYLALANYLHISTIDYLLYSINE; HUMAN ALBUMIN; HUMAN SERUM ALBUMIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 0036290521     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2002.6363     Document Type: Article

References (45)

1. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis
2. Efficacy and safety of recombinant human activated protein C for severe sepsis
3. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation
4. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
5. Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke
6. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation
7. The endothelium in sepsis: Source of and a target for inflammation
8. Regulation of blood coagulation by the protein C system
9. The protein C anticoagulant pathway
10. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium
11. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies
12. Alpha 2-macroglobulin binds and inhibits activated protein C
13. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome
14. Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: Relationship with systemic inflammation and haemostatic activation
15. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons
16. Interaction of activated protein C with serpins
17. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease
18. Plasma levels of activated protein C-protein C inhibitor complex in patients with hyperco-agulable states
19. Lactic acidosis in critical illness
20. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome
21. Temporal relationship of hepatocellular dysfunction and ischemia in sepsis
22. Patterns of mobilization of copper and iron following myocardial ischemia: Possible predictive criteria for tissue injury
23. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein
24. Trace element alterations in infectious diseases
25. Oxygen-derived free radicals in reperfusion injury
26. Role of free radicals and catalytic metal ions in human disease: An overview
27. 3+
28. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia
29. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species
30. Asp-Ala-His-Lys (DAHK) inhibits copper-induced oxidative DNA double strand breaks and telomere shortening
31. Rapid amidolytic assay of protein C in whole plasma using an activator from the venom of Agkistrodon contortrix
32. Homologous human blood protein separation using immobilized metal affinity chromatography: Protein C separation from prothrombin with application to the separation of factor IX and prothrombin
33. Synthesis rate of plasma albumin is a good indicator of liver albumin synthesis in sepsis
34. Lactated Ringer’s solution versus 3% albumin for resuscitation of a lethal intestinal ischemic shock in rats
35. Fluid resuscitation in circulatory shock: A comparison of the cardiore-spiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock
36. Oxygen consumption and central hemodynamics in septic shock treated with antibiotics, fluid infusions, and corticosteroids
37. Protective effects of hydroxyethyl starch-deferoxamine in early sepsis
38. Effects of hepatocellular iron imbalance on nitric oxide and reactive oxygen intermediates production in a model of sepsis
39. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
40. Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis
41. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects
42. Activated protein C versus protein C in severe sepsis
43. Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis